DAL vs TRDA · P/E 12, rev $61.64B vs P/E 12, rev $210.8M
Delta Air Lines Inc (DAL) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the DAL and TRDA stock pages for the full models.
Not investment advice.